Thank you very much, Mr. Chair, and thank you, gentlemen, for being here today with us to share your expertise.
I want to talk a little bit about mefloquine again. Ms. Gallant had some of the same questions I have.
You had talked about a decrease in use. Can you describe that decrease? Is that a minor decrease, or is it a massive decrease in use?